Related Experiment Video
Updated: Jun 15, 2026

Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
Cases of Pernio-Like Lesions after mRNA-1273 Vaccination with Clinical and Pathological Features: A Single-Center
Young-Wook Ryoo1, Ji-Min Yun1, Hyun-Wook Kim1
1Department of Dermatology, Keimyung University School of Medicine, Daegu, Korea.
Abstract:
The currently available coronavirus disease 2019 (COVID-19) vaccines in South Korea include mRNA (Moderna® and Pfizer®) and adenoviral vector (AstraZeneca® and Janssen®) vaccines. Dermatologic side effects of COVID-19 vaccines range from local injection site reactions to systemic eruptions, including morbilliform rashes or erythema multiforme. Pernio-like lesions, one of the most common cutaneous manifestations of COVID-19, have been rarely reported post-vaccination. Herein, we report four cases of pernio-like lesions, which were detected in a single tertiary hospital within 2 months, after the first dose of mRNA-1273 (Moderna®) vaccination was administered. In this study, we discuss the clinical and pathological features of our cases and compare them with those of previously reported cases of pernio-like lesions after COVID-19 vaccination. It is pivotal to realize that perniolike lesions can be a possible side effect of COVID-19 vaccination and that the number of patients experiencing this side effect is bound to be quite high in real-world clinical settings.
Insights
Pernio-like lesions, a skin condition, can occur after COVID-19 vaccination, particularly with mRNA vaccines. This study highlights four cases, suggesting this side effect may be more common than previously thought.
Area of Science:
- Dermatology
- Vaccinology
- Immunology
Background:
- South Korea offers mRNA (Moderna, Pfizer) and adenoviral vector (AstraZeneca, Janssen) COVID-19 vaccines.
- Dermatologic side effects are known, ranging from injection site reactions to systemic rashes.
- Pernio-like lesions, common in COVID-19, are rarely reported post-vaccination.
Observation:
- Four cases of pernio-like lesions were observed within two months at a single tertiary hospital.
- All cases occurred after the first dose of the mRNA-1273 (Moderna) vaccine.
- The study details the clinical and pathological characteristics of these cases.
Findings:
- Pernio-like lesions are a potential, albeit rare, cutaneous side effect of COVID-19 vaccination.
- Comparison with existing literature suggests an underreporting of this specific side effect.
- The observed cases provide further evidence linking mRNA vaccination to pernio-like reactions.
Implications:
- Clinicians should be aware of pernio-like lesions as a possible adverse reaction to COVID-19 vaccines.
- Increased recognition may lead to better patient management and understanding of vaccine-induced immune responses.
- Real-world data suggests the incidence of this side effect might be higher than currently documented.
Related Concept Videos
Cryptococcal Meningitis
Chickenpox
Atypical Pneumonia
Viral Meningitis
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

